Terbutaline (Acute Tocolysis / Fetal Bradycardia)
Brand names: Bricanyl
Terbutaline is a short-acting beta-2 adrenergic agonist used in obstetrics for acute, short-term uterine relaxation (tocolysis), for example to manage uterine hyperstimulation with fetal compromise or to facilitate intrapartum procedures.
The product information we hold does not support a dose for this page's specific use, route or population, so none is shown. Follow your local or national guideline, and confirm against the product SmPC.
The licensed dosing — for the medicine's licensed uses, which may differ from this page's — is on Terbutaline sulfate.
Clinical monograph
How it works
It stimulates myometrial beta-2 adrenoceptors, raising intracellular cyclic AMP and relaxing uterine smooth muscle to reduce contraction frequency and intensity.
Prescribing in practice
- It can cause significant maternal tachycardia, arrhythmia, hypotension, hyperglycaemia, and pulmonary oedema, so it is reserved for short-term use with maternal cardiovascular monitoring and is contraindicated in significant cardiac disease.
- It is used for acute, short-term tocolysis only and not for prolonged maintenance of pregnancy.
- It crosses the placenta and may cause transient fetal and neonatal tachycardia and hypoglycaemia.
Monitoring
Monitor maternal heart rate, blood pressure, and symptoms (chest pain, breathlessness) during administration, alongside the fetal heart rate.
Counselling the patient
- Explain that this medicine is given to relax the womb briefly and help the baby.
- A faster heartbeat and tremor are expected short-lived effects.
- Tell the team immediately about chest pain or breathlessness.
Evidence & guidelines
Acute beta-agonist tocolysis to relieve uterine hyperstimulation is established obstetric practice consistent with current prescribing references.
Reference: MHRA Drug Safety Update 2011 (terbutaline tocolysis); RCOG Green-top 1b (Tocolysis); ALSO Advanced Life Support in Obstetrics; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Murray Score for Acute Lung Injury (ALI/ARDS) · Respiratory Failure
- Simplified Acute Physiology Score 3 (SAPS 3) · ICU Scoring
- Killip Classification for Acute MI · Prognosis
- HEART Score for Major Adverse Cardiac Events · Chest Pain
- ADHERE Algorithm for Acute Decompensated Heart Failure · Risk Stratification
- HE-MACS (History and ECG-only Manchester Acute Coronary Syndromes) · ACS Risk Stratification